Search
Capadenoson
go.drugbank.com/drugs/DB16118InvestigationalCapadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).
alpha-methylthiofentanyl
go.drugbank.com/drugs/DB01470ExperimentalIllicitalpha-methylthiofentanyl is an opioid analgesic that is an analog of fentanyl.
HLX70
go.drugbank.com/drugs/DB16509Investigationalin healthy adult volunteers. … The condition targeted by HLX70 in this study is COVID-19.
(4R)-limonene
go.drugbank.com/drugs/DB08921Investigationalin perfumery. … Limonene is common in cosmetic products.
Synonyms: (4R)-1-methyl-4-isopropenylcyclohex-1-eneSelenocysteine
go.drugbank.com/drugs/DB02345InvestigationalA naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes.
Deracoxib
go.drugbank.com/drugs/DB11395ExperimentalVet approvedDeracoxib is a non-steroidal anti-inflammatory drug of the coxib class, used in veterinary medicine to treat osteoarthritis in dogs. … Deramaxx received FDA approval in August 2002 for "the control of post operative pain and inflammation associated with orthopedic surgery in dogs.
Human Umbilical Cord Mesenchymal Stem Cells
go.drugbank.com/drugs/DB15726InvestigationalThe explant method requires manual mincing of the tissue fragments and results in an inconsistent number of extracted MSCs. … Regardless of extraction method, the cells are usually expanded in vitro in laboratories using culture systems and bioreactors.
Opaganib
go.drugbank.com/drugs/DB12764Investigational[L27436] This drug has potential anticancer, anti-inflammatory, and antiviral activities, with potential applications in oncology, inflammation, the gastrointestinal system, and COVID-19.
siG12D LODER
go.drugbank.com/drugs/DB16329InvestigationalsiG12D LODER is under investigation in clinical trial NCT01676259 (A Phase 2 Study of Sig12d LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer).
Vorbipiprant
go.drugbank.com/drugs/DB16111InvestigationalCR6086 is under investigation in clinical trial NCT03163966 (A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in Dmard-naïve Patients With Early Rheumatoid Arthritis).